Facts & figures
As of: January, 2016
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992
2) primarily from own ressources, since 2001
3) primarily from own ressources
4) since 2009
5)since 2006
| Research Institutions of Campus Berlin-Buch Employees (total) |
2,091 |
|
| of these: | ||
| Max Delbrück Center for Molecular Medicine (MDC): | 1,624 | |
| Leibniz Institute of Molecular Pharmacology (FMP): | 275 | |
| Klinische Forschung Charité Campus Buch: | 192 | |
| Budget and third-party grants (total)1 | EUR 144 million | |
| Max Delbrück Center for Molecular Medicine (MDC): | EUR 104 million | |
| Leibniz Institute of Molecular Pharmacology (FMP): | EUR 24 million | |
| Klinische Forschung Charité Campus Buch: | EUR 16 million | |
| BiotechPark Berlin-Buch | ||
| Number of companies: | 63 | |
| Employees: | 800 | |
| Annual revenue: Percentage of third-party grants: 3,1% |
EUR 160 million |
|
| Hospitals & Patient-Care Institutions | ||
| Employees (total): of these: |
3,398 | |
| HELIOS Klinikum Berlin-Buch: | 2,550 | |
| Evangelische Lungenklinik: | 314 | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik): | 84 |
|
| Patient-care institutions: | 450 | |
| Number of patient beds: | 1232 | |
| Patients per year (inpatient and outpatient): | 199,400 | |
| Total investment volume of these: |
EUR 1.219 billion | |
| Infrastructure Campus Berlin-Buch1 | EUR 502 million | |
| HELIOS Klinikum Berlin-Buch² | EUR 304 million | |
| Evangelische Lungenklinik3 | EUR 49 million | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1 | EUR 38 million |
|
| LudwigPark3 | EUR 45 million | |
| Allées des Châteaux3 | EUR 23 million | |
| Widerker Vermögensverwaltung (Schlosspark-Passage)3 | EUR 28 million |
|
| Housing construction associations (HOWOGE3,4, EWG3,5, Hau+S3,5) | EUR 120 million |
|
| Ludwig Hoffmann Quartier | EUR 110 million |
News Buch Berlin
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
2021-04-14 / Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals.
more ...Eckert & Ziegler Receives Technetium Generator Licenses for Brazil
The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a li...
more ...Fasting acts as diet catalys
Those who need to change their eating habits to normalise their blood pressure should start with a fast. In the journal “Nature Communications”, MDC and ECRC scientists explain why patients can use it...
more ...Events Buch Berlin
27.04.2021, 09:00
Epigenetik und die große Frage: Beeinflusst die Umwelt unser Erbgut?
Die Epigenetik bietet konzeptionell neue Ansätze für das Verständnis genetischer Regulation von Entwicklungs- und Erkrankungs-Prozessen.
more ...14.09.2021, 09:00
GMP Biotech Summer School
Good Manufacturing Practice (GMP) Basic Course Biotechnology (English)
more ...17.02.2022, 09:00
Pharmacokinetics - Essentials for Project Managers in Biotech Companies
Basics in understanding pharmacokinetics in clinicial development - for non-physicians
more ...
